Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biogen Pharmachem Industries has informed that a meeting of the Board of Directors of the Company will be held on Monday January 22 2024, to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities.
The above information is a part of company’s filings submitted to BSE.